Group 1 - The core point of the news is that Jiuzhoutong's major shareholders have completed the early release and pledge of shares, with significant portions of their holdings being pledged [1] - As of November 23, 2025, the controlling shareholder Chuchang Investment and its concerted party Zhongshan Guangyin hold approximately 460 million shares and 335 million shares, accounting for 9.11% and 6.65% of the total share capital respectively [1] - After the completion of the share pledge and release, Chuchang Investment and Zhongshan Guangyin have pledged approximately 234 million shares and 320 million shares, representing 50.89% and 95.33% of their respective holdings, and 4.64% and 6.34% of the total share capital [1] Group 2 - For the first half of 2025, Jiuzhoutong's revenue composition shows that pharmaceutical wholesale and related businesses account for 95.94%, pharmaceutical manufacturing for 1.96%, pharmaceutical retail for 1.84%, healthcare and technology services for 0.17%, and other businesses for 0.08% [1] - As of the report date, Jiuzhoutong's market capitalization is 24.8 billion yuan [1]

Group 1 - The core point of the news is that Jiuzhoutong's major shareholders, Chuchang Investment and Zhongshan Guangyin, have completed the early release and pledge of shares, with significant portions of their holdings being pledged [1] - Chuchang Investment holds approximately 460 million shares (9.11% of total shares), while Zhongshan Guangyin holds about 335 million shares (6.65% of total shares) [1] - After the pledge completion, the total number of pledged shares by the major shareholders amounts to approximately 1.077 billion shares, representing 21.37% of the company's total shares [1] Group 2 - For the first half of 2025, Jiuzhoutong's revenue composition shows that pharmaceutical wholesale and related businesses account for 95.94%, while pharmaceutical manufacturing and retail account for 1.96% and 1.84% respectively [1] - The company's current market capitalization is 25.8 billion yuan [2]

Group 1 - The company Jiuzhoutong (SH 600998) announced that its shareholder Shanghai Hongkang holds approximately 1.088 billion shares, accounting for 21.58% of the total share capital [1] - After the early release of share pledges, Shanghai Hongkang has pledged a total of approximately 467 million shares, which is 42.87% of its holdings and 9.25% of the total share capital [1] - As of September 25, 2025, the controlling shareholder Chuchang Investment and its concerted parties hold approximately 2.291 billion shares, representing 45.43% of the total share capital [1] Group 2 - Following the early release of share pledges, the total number of pledged shares held by Chuchang Investment and its concerted parties is approximately 1.077 billion shares, reducing the pledged proportion of their holdings to 47.01% and the total share capital to 21.36% [1] - For the first half of 2025, Jiuzhoutong's revenue composition is as follows: pharmaceutical wholesale and related businesses account for 95.94%, pharmaceutical manufacturing for 1.96%, pharmaceutical retail for 1.84%, medical health and technology services for 0.17%, and other businesses for 0.08% [1] - As of the report date, Jiuzhoutong's market capitalization is 24.6 billion yuan [1]